Skip to main content
. 2020 Jul 29;80(12):1259–1264. doi: 10.1007/s40265-020-01370-4

Key clinical trials of inebilizumab (Viela Bio)

Drug(s) Indication Phase Status Location(s) Identifier
Inebilizumab, placebo Neuromyelitis optica spectrum disorder II/III Completed Multinational

NCT02200770

EudraCT2014-000253-36 

N-MOmentum

CD-IA-MEDI-551-1155

Inebilizumab, VIB4920 Kidney transplant desensitization II Active (not recruiting) USA

NCT04174677

VIB0551.P2.S1